3 ms·

(As someone who knows next to nothing about medicine or microbiology) I’m curious how they already know which antibodies to look for? Are antibodies unique to

(As someone who knows next to nothing about medicine or microbiology) I’m curious how they already know which antibodies to look for? Are antibodies unique to each virus? Is it possible that some people have stumbled upon antibody X at some point in their lives that maybe isn’t perfect for fighting off this new coronavirus but still helps? Along the same lines, is it possible some people have antibodies IgM and IgG from some other illness they’ve encountered in their lives? Or is the presence of those antibodies conclusive evidence that they’ve been infected with COVID-19?

sitic 7y ago
From https://www.sciencemag.org/news/2020/04/unprecedented-nationwide-blood-studies-seek-track-us-coronavirus-spread https://www.sciencemag.org/news/2020/04/unprecedented-nation... > We’re also concerned about the related coronaviruses that cause the common cold in humans. These viruses induce antibody responses that, at least temporarily “neutralize” the virus, but they don’t appear to last. Because the neutralizing antibodies wane over the course of 1 to 2 years, people can be reinfected with the exact same coronavirus 1 or 2 years later. The simplistic idea is that people are going to get infected with SARS-CoV-2 and then they’ll be resistant to infection for the rest of their lives, and that herd immunity will accumulate over time, etc. But if this is anything like the more traditional coronaviruses that cause common colds, you’ll get robust neutralizing activity at first, but it will wane over time. And so our studies are really focused on assessing that issue of persistence of immunity from reinfection. [...] > Q: What happens when SARS-CoV-2 infects a person who has antibodies to the other four coronaviruses that infect humans and cause the common cold? > A: We were on a call today with the CDC about this. If we look at people who just went through a SARS-CoV-2 infection and have a burst of antibodies against the virus, they’ve also boosted their pre-existing antibodies against the classic cold coronavirus. And the earliest antibody responses that CDC researchers have seen in careful longitudinal studies to SARS-CoV-2 are actually those cross-reactive memory responses to the classic cold coronaviruses. > Q: How might these cross-reactive antibody responses matter? > A: The immune memory to previous infections may help control infection with those cold viruses and even ameliorate symptoms of SARS-CoV-2 infection. But it can cause problems with the accuracy of SARS-CoV-2 diagnostics, as people reinfected with common cold coronaviruses could score as false positive with some SARS-CoV-2 serological assays.
refurb 7y ago
They are looking for antibodies to the spike protein on COVID-19. So if a person has those, then it's proof that they've been exposed to it. Antibodies are unique for each virus, but there can be "cross-reactivity" where an antibody for a different virus also binds to COVID-19. Yes, it is possible that there are people out there who have antibodies that bind to COVID-19, who have never been infected with it, but rather have an antibody that cross-reacts with COVID-19. But it would be a very rare occurrence. So having COVID-19 antibodies isn't a perfect was to tell if a person has been exposed, but it's a very good way to do it since antibodies is highly correlated with exposure.
- StandardFuture 7y ago
  Would antibodies that can attach to COVID-19 but were produced from a different viral infection potentially make you immune to COVID-19?
  - abakker 7y ago
    I think that is the holy grail.
  - toomanybeersies 7y ago
    That was the case with Smallpox and Cowpox, and the original vaccine.
    - elliekelly 7y ago
      Interesting! From the smallpox wikipedia page: > The term vaccine derives from the Latin word for cow, reflecting the origins of smallpox vaccination.
  - refurb 7y ago
    Yes. It’s similar to the AAV (adeno-associated virus), a common virus. There are multiple subtypes, but often an antibody to one will bind to other variants, making you immune.
  - deleted 7y ago
maxerickson 7y ago
IgM and IgG are types of antibodies: https://kidshealth.org/en/parents/test-immunoglobulins.html https://kidshealth.org/en/parents/test-immunoglobulins.html Specialized versions are produced in response to individual disease. They are similar to each other but not the same.

sitic 7y ago

From https://www.sciencemag.org/news/2020/04/unprecedented-nationwide-blood-studies-seek-track-us-coronavirus-spread https://www.sciencemag.org/news/2020/04/unprecedented-nation... > We’re also concerned about the related coronaviruses that cause the common cold in humans. These viruses induce antibody responses that, at least temporarily “neutralize” the virus, but they don’t appear to last. Because the neutralizing antibodies wane over the course of 1 to 2 years, people can be reinfected with the exact same coronavirus 1 or 2 years later. The simplistic idea is that people are going to get infected with SARS-CoV-2 and then they’ll be resistant to infection for the rest of their lives, and that herd immunity will accumulate over time, etc. But if this is anything like the more traditional coronaviruses that cause common colds, you’ll get robust neutralizing activity at first, but it will wane over time. And so our studies are really focused on assessing that issue of persistence of immunity from reinfection. [...] > Q: What happens when SARS-CoV-2 infects a person who has antibodies to the other four coronaviruses that infect humans and cause the common cold? > A: We were on a call today with the CDC about this. If we look at people who just went through a SARS-CoV-2 infection and have a burst of antibodies against the virus, they’ve also boosted their pre-existing antibodies against the classic cold coronavirus. And the earliest antibody responses that CDC researchers have seen in careful longitudinal studies to SARS-CoV-2 are actually those cross-reactive memory responses to the classic cold coronaviruses. > Q: How might these cross-reactive antibody responses matter? > A: The immune memory to previous infections may help control infection with those cold viruses and even ameliorate symptoms of SARS-CoV-2 infection. But it can cause problems with the accuracy of SARS-CoV-2 diagnostics, as people reinfected with common cold coronaviruses could score as false positive with some SARS-CoV-2 serological assays.

refurb 7y ago

They are looking for antibodies to the spike protein on COVID-19. So if a person has those, then it's proof that they've been exposed to it. Antibodies are unique for each virus, but there can be "cross-reactivity" where an antibody for a different virus also binds to COVID-19. Yes, it is possible that there are people out there who have antibodies that bind to COVID-19, who have never been infected with it, but rather have an antibody that cross-reacts with COVID-19. But it would be a very rare occurrence. So having COVID-19 antibodies isn't a perfect was to tell if a person has been exposed, but it's a very good way to do it since antibodies is highly correlated with exposure.

StandardFuture 7y ago
Would antibodies that can attach to COVID-19 but were produced from a different viral infection potentially make you immune to COVID-19?
- abakker 7y ago
  I think that is the holy grail.
- toomanybeersies 7y ago
  That was the case with Smallpox and Cowpox, and the original vaccine.
  - elliekelly 7y ago
    Interesting! From the smallpox wikipedia page: > The term vaccine derives from the Latin word for cow, reflecting the origins of smallpox vaccination.
- refurb 7y ago
  Yes. It’s similar to the AAV (adeno-associated virus), a common virus. There are multiple subtypes, but often an antibody to one will bind to other variants, making you immune.
- deleted 7y ago

maxerickson 7y ago

IgM and IgG are types of antibodies: https://kidshealth.org/en/parents/test-immunoglobulins.html https://kidshealth.org/en/parents/test-immunoglobulins.html Specialized versions are produced in response to individual disease. They are similar to each other but not the same.